Michael Brent Tignor - Mar 8, 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP & Chief HR Officer
Signature
/s/ Hatsuki Miyata, Attorney-in-Fact for Michael Brent Tignor
Stock symbol
BCPC
Transactions as of
Mar 8, 2024
Transactions value $
-$482,305
Form type
4
Date filed
3/12/2024, 04:30 PM
Previous filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Options Exercise $359K +4.2K +44.18% $85.40 13.7K Mar 8, 2024 Direct F1, F2
transaction BCPC Common Stock Sale -$512K -3.26K -23.79% $157.07 10.4K Mar 8, 2024 Direct F3
transaction BCPC Common Stock Sale -$329K -2.08K -19.89% $158.22 8.37K Mar 8, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Options (right to buy) Options Exercise $0 -4.2K -50% $0.00 4.2K Mar 8, 2024 Common Stock 4.2K $85.40 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of fully vested non-qualified stock options.
F2 Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan.
F3 This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4 This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F5 Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable.